SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-165735
Filing Date
2024-06-21
Accepted
2024-06-21 16:30:55
Documents
14
Period of Report
2024-06-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d821942d8k.htm   iXBRL 8-K 25192
2 EX-10.1 d821942dex101.htm EX-10.1 25555
  Complete submission text file 0001193125-24-165735.txt   182644

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bvs-20240619.xsd EX-101.SCH 2853
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bvs-20240619_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bvs-20240619_pre.xml EX-101.PRE 11710
17 EXTRACTED XBRL INSTANCE DOCUMENT d821942d8k_htm.xml XML 3770
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

IRS No.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37844 | Film No.: 241060933
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)